CPRX

Catalyst Pharmaceuticals Stock Analysis

AI Rating

Great
  • Quality9/10
  • Growth↑ 9/10
  • Value↑ 7/10
Catalyst Pharmaceuticals sales and earnings growth
CPRX Growth
Great
  • Revenue Y/Y↑ 19.78%
  • EPS Y/Y↑ 26.81%
  • FCF Y/Y↓ -12.81%
Catalyst Pharmaceuticals gross and profit margin trends
CPRX Profitability
Great
  • Gross margin ↑ 85.20%
  • EPS margin↑ 36.40%
  • ROIC 5Y↑ 400.87%
Catalyst Pharmaceuticals net debt vs free cash flow
CPRX Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 999.0

Catalyst Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗